NO3061464T3 - - Google Patents

Info

Publication number
NO3061464T3
NO3061464T3 NO15156714A NO15156714A NO3061464T3 NO 3061464 T3 NO3061464 T3 NO 3061464T3 NO 15156714 A NO15156714 A NO 15156714A NO 15156714 A NO15156714 A NO 15156714A NO 3061464 T3 NO3061464 T3 NO 3061464T3
Authority
NO
Norway
Application number
NO15156714A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO3061464T3 publication Critical patent/NO3061464T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1051—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from breast, e.g. the antibody being herceptin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO15156714A 2015-02-26 2015-02-26 NO3061464T3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15156714.6A EP3061464B1 (fr) 2015-02-26 2015-02-26 Solutions radiopharmaceutiques avec des propriétés avantageuses

Publications (1)

Publication Number Publication Date
NO3061464T3 true NO3061464T3 (fr) 2018-03-24

Family

ID=52629380

Family Applications (1)

Application Number Title Priority Date Filing Date
NO15156714A NO3061464T3 (fr) 2015-02-26 2015-02-26

Country Status (3)

Country Link
EP (1) EP3061464B1 (fr)
ES (1) ES2657388T3 (fr)
NO (1) NO3061464T3 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017220767A1 (fr) * 2016-06-24 2017-12-28 Sciencons AS Préparation d'anticorps monoclonaux marqués au pb212
EP3563875A1 (fr) * 2018-05-04 2019-11-06 Ceské vysoké ucení technické v Praze Le radium pour utilisation dans la thérapie aux radionuclides, en combinaison avec une thérapie qui influence le métabolisme du calcium

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO312708B1 (no) * 2000-02-21 2002-06-24 Anticancer Therapeutic Inv Sa Radioaktive liposomer til terapi
EP1735013B1 (fr) * 2004-02-20 2012-02-08 Algeta ASA Particules d'hydroxyapatite emettrices de rayons alpha et beta

Also Published As

Publication number Publication date
EP3061464A1 (fr) 2016-08-31
ES2657388T3 (es) 2018-03-05
EP3061464B1 (fr) 2017-10-25

Similar Documents

Publication Publication Date Title
BR112018002713A2 (fr)
RU2017127720A3 (fr)
BR112017027893A2 (fr)
BR112018005619A2 (fr)
NO3061464T3 (fr)
BE2015C047I2 (fr)
BE2015C044I2 (fr)
BR0002802B1 (fr)
BR0008132B1 (fr)
BR0000126B1 (fr)
BRPI0501033B1 (fr)
BR122014000731B1 (fr)
BR0000695B1 (fr)
BR0000763F1 (fr)
BR0001536B1 (fr)
BR0001684B1 (fr)
BR0001810B1 (fr)
CN303070361S (fr)
BR0007747B1 (fr)
BR0002033B1 (fr)
BR0002402B1 (fr)
BR0002435B1 (fr)
BR0002694B1 (fr)
BR0009994B1 (fr)
CN303084951S (fr)